Smad6 is induced by BMP‐2 and modulates chondrocyte differentiation

Journal of Orthopaedic Research - Tập 21 - Trang 908-913 - 2003
Xeufeng Li1, Andreia M Ionescu1, Edward M Schwarz1, Xinping Zhang1, Hicham Drissi1, J.Edward Puzas1, Randy N Rosier1, Michael J Zuscik1, Regis J O’Keefe1
1Center for Musculoskeletal Research, Department of Orthopaedics, University of Rochester Medical Center, 601 Elmwood Avenue, Box 665, Rochester, NY 14642, USA

Tóm tắt

AbstractBMPs regulate cartilage differentiation and have been approved for clinical use as stimulators of bone repair. BMP signaling is complex and there are multiple potential points of regulation, including modulation of Smad signaling, which is inhibited by both Smad6 and Smad7. In the current manuscript we assessed the expression and biological function of Smad6 during chondrocyte differentiation. We found that the induction of chondrocyte differentiation by BMP‐2 in chicken sternal embryonic chondrocytes was accompanied by a marked increase in Smad6 mRNA and protein levels. A morpholino antisense oligonucleotide complementary to Smad6 reduced the expression of Smad6 protein and enhanced the stimulatory effect of BMP‐2 on both colX and alkaline phosphatase activity. In contrast, over‐expression of Smad6 blocked BMP‐2 mediated induction of the type X collagen promoter, b2‐640 Luc. Therefore, expression studies as well as gain and loss of function experiments suggest that Smad6 participates in an important negative feedback loop whereby BMP‐2 mediated effects on chondrocyte differentiation are reduced by induction of Smad6. Additional studies are required to determine the extent to which this pathway participates in pathologic processes involving cartilage. © 2003 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.

Tài liệu tham khảo

10.1006/bbrc.1998.9170 Ballock RT, 2000, Thyroid hormone regulates terminal differentiation of growth plate chondrocytes through local induction of bone morphogenetic proteins, Trans Orthop Res Soc, 25, 160 10.1359/jbmr.1999.14.11.1805 10.1210/endo.138.7.5125 10.1097/00003086-199810001-00013 10.1002/jbmr.5650100310 10.1002/(SICI)1097-4644(20000615)77:4<678::AID-JCB15>3.0.CO;2-P 10.1210/endo.141.12.7848 10.1006/bcmd.2002.0487 10.1038/72835 10.1089/108729000421448 10.1002/jor.1100160212 10.1359/jbmr.1999.14.4.475 10.1002/1097-4644(20010501)81:2<284::AID-JCB1043>3.0.CO;2-D 10.1083/jcb.200106023 10.1016/S0092-8674(00)80303-7 10.1038/39355 10.1074/jbc.275.9.6075 10.1074/jbc.274.19.13637 10.1074/jbc.C000580200 10.1089/oli.1.1996.6.169 10.1006/dbio.1998.9181 10.1002/mrd.10202 10.1074/jbc.273.39.25364 10.1007/s003350010032 10.1006/bbrc.1998.8200 10.1359/jbmr.1998.13.10.1521 10.1126/science.273.5275.613 10.1083/jcb.148.4.679 10.1016/S0092-8674(00)81556-1 Wrana JL, 1992, TGF‐beta signals through a heteromeric protein kinase receptor complex, Cell, 71, 1002, 10.1016/0092-8674(92)90395-S 10.1006/dbio.1999.9419 10.1002/jbm.1289 10.1073/pnas.98.3.974